PURE Bioscience, Inc. (PURE)

PURE Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Year	2023	2022	2021	2020	2019
Net Income	-3.96	-3.5	-2.32	-0.01	-6.56
Depreciation & Amortization	0.12	0.21	0.17	0.19	0.24
Share-Based Compensation	0.32	0.57	0.84	0.79	2.45
Other Operating Activities	0.24	0.3	0.14	-0.3	0.88
Operating Cash Flow	-3.28	-2.42	-1.17	0.67	-2.99
Capital Expenditures	-0.03	-0.08	-0.52	-0.06	-0.01
Investing Cash Flow	-0.03	-0.08	-0.52	-0.06	-0.01
Common Stock Issued	0	3.5	0	2.83	1.71
Other Financing Activities	1.01	-	0.24	-	0.84
Financing Cash Flow	1.01	3.5	0.24	2.83	2.55
Net Cash Flow	-2.3	1	-1.45	3.44	-0.45
Free Cash Flow	-3.31	-2.5	-1.69	0.61	-3
Free Cash Flow Margin	-176.40%	-134.86%	-42.98%	8.83%	-157.31%
Free Cash Flow Per Share	-0.03	-0.03	-0.02	0.01	-0.04

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.